Obiamiwe Umeh MD MSc.
Transplant/Immunocompromised States
Vice- President, Clinical Development, Takeda Pharmaceutical Company
Join to View Full Profile
125 Binney StreetCambridge, MA 02142
Dr. Umeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard Business School (Executive Education)Certificate Course, Program For Leadership Development (PLD 21), 2015 - 2016
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2002 - 2005
Brooklyn Hospital CenterResidency, Internal Medicine, 1999 - 2002
University of Nigeria Faculty of MedicineClass of 1995
Certifications & Licensure
IN State Medical License 2001 - Present
CA State Medical License 2002 - 2026
Clinical Trials
- Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis Start of enrollment: 2011 Jun 20
- Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 94 citationsEfficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled a...Myra W. Popejoy, David L. Paterson, Daniel J Cloutier, Jennifer A. Huntington, Benjamin F. Miller
The Journal of Antimicrobial Chemotherapy. 2017-01-01 - 31 citationsEfficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: res...Jennifer A. Huntington, George Sakoulas, Obiamiwe Umeh, Daniel J Cloutier, Judith N. Steenbergen
The Journal of Antimicrobial Chemotherapy. 2016-07-01 - 5 citationsCeftolozane-tazobactam versus levofloxacin in urinary tract infection – Authors' replyFlorian M.E. Wagenlehner, Obiamiwe Umeh, Rabih O. Darouiche
Lancet. 2015-09-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
